Barclays analyst Mathieu Robilliard lowered the firm’s price target on Iridium (IRDM) to $31 from $38 and keeps an Overweight rating on the shares. The firm reduced estimates post earnings to reflect less certain growth opportunities in Iridium’s new verticals. However, the firm believes the company’s growth remains attractive and the stock’s valuation is supportive.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRDM:
- CRSP, ABSI, IRDM: Cathie Wood Offloads $16.4M of CRISPR Therapeutics Stock, Buys Absci and Iridium
- Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
- Cathie Wood Bets Big on This Satellite Stock, Exits COIN and RBLX Positions
- Iridium price target lowered to $39 from $47 at Raymond James
- Iridium Communications Reports Q2 2025 Earnings and Outlook